D-1517-2016 Class III Terminated

Recalled by Reckitt Benckiser LLC — Parsippany, NJ

FDA drug recall D-1517-2016 was initiated by Reckitt Benckiser LLC on Aug 3, 2016 and is designated Class III. Reason for recall: Labeling: Label Error on Declared Strength; label on outer carton incorrectly states Diphenhydramine 25 mg instead of 12.5 mg. Also, quantity is incorrectly stated as 30 daytime and 30 nighttime… The recall status is terminated (terminated Mar 5, 2018). Affected quantity: 738 boxes.

Recall details

Product Type
Drugs
Report Date
Sep 28, 2016
Initiation Date
Aug 3, 2016
Termination Date
Mar 5, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
738 boxes

Product description

Mucinex Sinus-Max Day Night, 60 caplets, Dist. by Reckitt Benckiser, Parsippany, NJ 07054-0224 UPC 363824951737 NDC 63824-207-60

Reason for recall

Labeling: Label Error on Declared Strength; label on outer carton incorrectly states Diphenhydramine 25 mg instead of 12.5 mg. Also, quantity is incorrectly stated as 30 daytime and 30 nighttime instead of 36 daytime and 24 nighttime.

Distribution pattern

FL, MA and NJ

Code information

WO00809739, 9/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1517-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Reckitt Benckiser LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1517-2016. Report a data issue: hello@regdatalab.com.